Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells

Qu,Zhongyuan; Zou,Xiang; Zhang,Xiujuan; Sheng,Jiejing; Wang,Yumeng; Wang,Jiaqi; Wang,Chao; Ji,Yubin

doi:10.3892/mmr.2015.4683

Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells

Authors:
- Zhongyuan Qu
- Xiang Zou
- Xiujuan Zhang
- Jiejing Sheng
- Yumeng Wang
- Jiaqi Wang
- Chao Wang
- Yubin Ji
View Affiliations

Affiliations: School of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang 150076, P.R. China, Engineering Research Center of Natural Antineoplastic Drugs, Harbin University of Commerce, Harbin, Heilongjiang 150076, P.R. China
Published online on: December 14, 2015 https://doi.org/10.3892/mmr.2015.4683
Pages: 1336-1344

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect of chelidonine on mitotic slippage and apoptotic-like death in SGC-7901 human gastric cancer cells. The MTT assay was performed to detect the antiproliferative effect of chelidonine. Following treatment with chelidonine (10 µmol/l), the ultrastructure changes in SGC‑7901, MCF‑7 and HepG2 cells were observed by transmission electron microscopy. The effects of chelidonine on G2/M phase arrest and apoptosis of SGC‑7901 cells were determined by flow cytometry. Indirect immunofluorescence assay and laser scanning confocal microscopy (LSCM) were used to detect the phosphorylation level of histone H3 (Ser10) and microtubule formation was detected using LSCM following immunofluorescent labeling. Subsequent to treatment with chelidonine (10 µmol/l), expression levels of mitotic slippage‑associated proteins, including BUB1 mitotic checkpoint serine/threonine kinase B (BubR1), cyclin‑dependent kinase 1 (Cdk1) and cyclin B1, and apoptosis‑associated protein, caspase‑3 were examined by western blotting at 24, 48 and 72 h. The half maximal inhibitory concentration of chelidonine was 23.13 µmol/l over 48 h and chelidonine induced G2/M phase arrest of cells. The phosphorylation of histone H3 at Ser10 was significantly increased following treatment with chelidonine for 24 h, indicating that chelidonine arrested the SGC‑7901 cells in the M phase. Chelidonine inhibited microtubule polymerization, destroyed microtubule structures and induced cell cycle arrest in the M phase. Giant cells were observed with multiple micronuclei of varying sizes, which indicated that following a prolonged arrest in the M phase, the cells underwent mitotic catastrophe. Western blotting demonstrated that the protein expression levels of BubR1, cyclin B1 and Cdk1 decreased significantly between 48 and 72 h. Low expression levels of BubR1 and inactivation of the cyclin B1‑Cdk1 complex results in the cells being arrested at mitosis and leads to mitotic slippage. In addition, apoptotic morphological changes in multinucleated cells were observed, the apoptosis rates increased gradually with administration of chelidonine in a time‑dependent manner and the protein levels of caspase‑3 increased significantly between 24 and 72 h. Thus, chelidonine induces mitotic slippage, and apoptotic‑like death occurs in SGC‑7901 cells undergoing mitotic catastrophe. Gastric cancer is a common malignancy, and ranks second in overall cancer‑associated mortalities worldwide. The present study demonstrated that chelidonine induces M phase arrest and mitotic slippage of SGC‑7901 human gastric carcinoma cells via downregulating the expression of BubR1, Cdk1 and cyclin B1 proteins. With the prolongation of chelidonine treatment, the giant cells with multiple micronuclei underwent mitotic slippage and were maintained in the G1 phase and did not survive. A number of multinucleated cells underwent apoptosis via a caspase‑dependent signaling pathway. The current study proposes that chelidonine induces mitotic slippage and apoptotic-like death of SGC-7901 cells.

View Figures

View References

1	De Vita F, Di Martino N, Fabozzi A, Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V, Sforza V, Marano L, et al: Clinical management of advanced gastric cancer: The role of new molecular drugs. World J Gastroenterol. 20:14537–14558. 2014. View Article : Google Scholar : PubMed/NCBI
2	Cives M, Ciavarella S, Rizzo FM, De Matteo M, Dammacco F and Silvestris F: Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe. Cell Signal. 25:1108–1117. 2013. View Article : Google Scholar : PubMed/NCBI
3	Zhao GP, Dai S, Chen RS, Wen HM, Yin L, Shi LW, Shi XD, Liu WL, Liu XH, Li Y, et al: Dictionary Chinese materia medica. Dictionary Chinese Materia Medica. Yu HA and Liu SF: 1. 2nd edition. Shanghai Science and Technology Press; Shanghai: pp. p10002006
4	Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. Pharmacopoeia of the People's Republic of China. Zhao YY: 1. 10th edition. Medicine Science and Technology Press of China; Beijing: pp. p1092015
5	He ZM, Tong JM and Gong FC: Study on the analgesic effect of Chelidonium majus L. Chin Tradit Herb Drugs. 34:837–838. 2003.
6	Colombo ML and Bosisio E: Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacol Res. 33:127–134. 1996. View Article : Google Scholar : PubMed/NCBI
7	Noureini SK and Wink M: Transcriptional down regulation of hTERT and senescence induction in HepG2 cells by chelidonine. World J Gastroenterol. 15:3603–3610. 2009. View Article : Google Scholar : PubMed/NCBI
8	Paul A, Bishayee K, Ghosh S, Mukherjee A, Sikdar S, Chakraborty D, Boujedaini N and Khuda-Bukhsh AR: Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT signalling pathways. J Chin Integ Med. 10:1025–1038. 2012. View Article : Google Scholar
9	Paul A, Das S, Das J, Samadder A and Khuda-Bukhsh AR: Cytotoxicity and apoptotic signalling cascade induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells in vitro and bioavailability of nano-chelidonine in mice in vivo. Toxicol Lett. 222:10–22. 2013. View Article : Google Scholar : PubMed/NCBI
10	Park JE, Cuong TD, Hung TM, Lee I, Na M, Kim JC, Ryoo S, Lee JH, Choi JS, Woo MH and Min BS: Alkaloids from Chelidonium majus and their inhibitory effects on LPS-induced NO production in RAW264.7 cells. Bioorg Med Chem Lett. 21:6960–6963. 2011. View Article : Google Scholar : PubMed/NCBI
11	Heinle H, Hagelauer D, Pascht U, Kelber O and Weiser D: Intestinal spasmolytic effects of STW 5 (Iberogast) and its components. Phytomedicine. 13(Suppl 5): 75–79. 2006. View Article : Google Scholar : PubMed/NCBI
12	Iagodina OV, Niko'/skaia EB and Faddeeva MD: Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their derivative drugs. Tsitologiia. 45:1032–1037. 2003.In Russian.
13	Paul A, Das J, Das S, Samadder A and Khuda-Bukhsh AR: Poly (lactide-co-glycolide) nano-encapsulation of chelidonine, an active bioingredient of greater celandine (Chelidonium majus), enhances its ameliorative potential against cadmium induced oxidative stress and hepatic injury in mice. Environ Toxicol Pharmacol. 36:937–947. 2013. View Article : Google Scholar : PubMed/NCBI
14	Koriem KM, Arbid MS and Asaad GF: Chelidonium majus leaves methanol extract and its chelidonine alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats. J Nat Med. 67:159–167. 2013. View Article : Google Scholar
15	Staniszewski A, Slesak B, Kołodziej J, Harłozińska-Szmyrka A and Nowicky JW: Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain). Drugs Exp Clin Res. 18(Suppl): 63–67. 1992.PubMed/NCBI
16	Kadan P, Korsh OB and Melnyk A: Ukrain therapy of recurrent breast cancer with lung metastases (case report). Drugs Exp Clin Res. 22:243–245. 1996.PubMed/NCBI
17	Uglyanitsa KN, Nechiporenko NA, Nefyodov LI, Doroshenko YM, Brzosko W and Nowicky W: Results of Ukrain monotherapy of prostate cancer. Drugs Exp Clin Res. 26:191–193. 2000.
18	Zemskov V, Prokopchuk O, Susak Y, Zemskov S, Tkachenko O, Hodysh Y and Nowicky W: Efficacy of ukrain in the treatment of pancreatic cancer. Langenbecks Arch Surg. 387:84–89. 2002. View Article : Google Scholar : PubMed/NCBI
19	El-Readi MZ, Eid S, Ashour ML, Tahrani A and Wink M: Modulation of multidrug resistance in cancer cells by cheli-donine and Chelidonium majus alkaloids. Phytomedicine. 20:282–294. 2013. View Article : Google Scholar
20	Hammerová J, Uldrijan S, Táborská E and Slaninová I: Benzo[c] phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status. J Dermatol Sci. 62:22–35. 2011.
21	Kaminskyy V, Kulachkovskyy O and Stoika R: A decisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids. Toxicol Lett. 177:168–181. 2008. View Article : Google Scholar : PubMed/NCBI
22	Vitale I, Galluzzi L, Castedo M and Kroemer G: Mitotic catastrophe: A mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 12:385–392. 2011. View Article : Google Scholar : PubMed/NCBI
23	Caruso R, Fedele F, Lucianò R, Branca G, Parisi C, Paparo D and Parisi A: Mitotic catastrophe in malignant epithelial tumors: The pathologis'/s viewpoint. Ultrastruct Pathol. 35:66–71. 2011. View Article : Google Scholar : PubMed/NCBI
24	Lindgren T, Stigbrand T, Johansson L, Riklund K and Eriksson D: Alterations in gene expression during radiation-induced mitotic catastrophe in HeLa Hep2 cells. Anticancer Res. 34:3875–3880. 2014.PubMed/NCBI
25	Grzanka D, Marszałek A, Izdebska M, Gackowska L, Andrzej Szczepanski M and Grzanka A: Actin cytoskeleton reorganization correlates with cofilin nuclear expression and ultrastructural changes in cho aa8 cell line after apoptosis and mitotic catastrophe induction by doxorubicin. Ultrastruct Pathol. 35:130–138. 2011. View Article : Google Scholar : PubMed/NCBI
26	Wang X, Wu E, Wu J, Wang TL, Hsieh HP and Liu X: An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells. PLoS One. 8:e656862013. View Article : Google Scholar : PubMed/NCBI
27	Magalska A, Sliwinska M, Szczepanowska J, Salvioli S, Franceschi C and Sikora E: Resistance to apoptosis of HCW-2 cells can be overcome by curcumin- or vincristine-induced mitotic catastrophe. Int J Cancer. 119:1811–1818. 2006. View Article : Google Scholar : PubMed/NCBI
28	Mansilla S, Bataller M and Portugal J: Mitotic catastrophe as a consequence of chemotherapy. Anticancer Agents Med Chem. 6:589–602. 2006. View Article : Google Scholar : PubMed/NCBI
29	Kemény-Beke A, Aradi J, Damjanovich J, Beck Z, Facskó A, Berta A and Bodnár A: Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine. Cancer Lett. 237:67–75. 2006. View Article : Google Scholar
30	Philchenkov A, Kaminskyy V, Zavelevich M and Stoika R: Apoptogenic activity of two benzophenanthridine alkaloids from Chelidonium majus L. does not correlate with their DNA damaging effects. Toxicol In Vitro. 22:287–295. 2008. View Article : Google Scholar
31	Panzer A, Joubert AM, Bianchi PC, Hamel E and Seegers JC: The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways. Eur J Cell Biol. 80:111–118. 2001. View Article : Google Scholar : PubMed/NCBI
32	Ji YB, Qu ZY and Zou X: Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. Exp Toxicol Pathol. 63:69–78. 2011. View Article : Google Scholar
33	Kundu S, Kim TH, Yoon JH, Shin HS, Lee J, Jung JH and Kim HS: Viriditoxin regulates apoptosis and autophagy via mitotic catastrophe and microtubule formation in human prostate cancer cells. Int J Oncol. 45:2331–2340. 2014.PubMed/NCBI
34	Roy RV, Suman S, Das TP, Luevano JE and Damodaran C: Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells. J Nat Prod. 76:1909–1915. 2013. View Article : Google Scholar : PubMed/NCBI
35	de-Sá-Júnior PL, Pasqualoto KF, Ferreira AK, Tavares MT, Damião MC, de Azevedo RA, Câmara DA, Pereira A, de Souza DM and Parise Filho R: RPF101, a new capsaicin-like analogue, disrupts the microtubule network accompanied by arrest in the G2/M phase, inducing apoptosis and mitotic catastrophe in the MCF-7 breast cancer cells. Toxicol Appl Pharmacol. 266:385–398. 2013. View Article : Google Scholar
36	Suematsu T, Li Y, Kojima H, Nakajima K, Oshimura M and Inoue T: Deacetylation of the mitotic checkpoint protein BubR1 at lysine 250 by SIRT2 and subsequent effects on BubR1 degradation during the prometaphase/anaphase transition. Biochem Biophys Res Commun. 453:588–594. 2014. View Article : Google Scholar : PubMed/NCBI
37	Yu H: Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin Cell Biol. 14:706–714. 2002. View Article : Google Scholar : PubMed/NCBI
38	Lane SI and Jones KT: Non-canonical function of spindle assembly checkpoint proteins after APC activation reduces aneuploidy in mouse oocytes. Nat Commun. 5:34442014. View Article : Google Scholar : PubMed/NCBI
39	Kapanidou M, Lee S and Bolanos-Garcia VM: BubR1 kinase: Protection against aneuploidy and premature aging. Trends Mol Med. 21:364–372. 2015. View Article : Google Scholar : PubMed/NCBI
40	Bolanos-Garcia VM, Nilsson J and Blundell TL: The architecture of the BubR1 tetratricopeptide tandem repeat defines a protein motif underlying mitotic checkpoint-kinetochore communication. Bioarchitecture. 2:23–27. 2012. View Article : Google Scholar : PubMed/NCBI
41	Ibrahim B: Systems biology modeling of five pathways for regulation and potent inhibition of the anaphase-promoting complex (APC/C): Pivotal roles for MCC and BubR1. OMICS. 19:294–305. 2015. View Article : Google Scholar : PubMed/NCBI
42	Lentini L, Piscitello D, Veneziano L and Di Leonardo A: Simultaneous reduction of MAD2 and BUBR1 expression induces mitotic spindle alterations associated with p53 dependent cell cycle arrest and death. Cell Biol Int. 38:933–941. 2014. View Article : Google Scholar : PubMed/NCBI
43	Patel D and McCance DJ: Compromised spindle assembly checkpoint due to altered expression of Ubch10 and Cdc20 in human papillomavirus type 16 E6- and E7-expressing keratinocytes. J Virol. 84:10956–10964. 2010. View Article : Google Scholar : PubMed/NCBI
44	Lara-Gonzalez P, Scott MI, Diez M, Sen O and Taylor SS: BubR1 blocks substrate recruitment to the APC/C in a KEN-box-dependent manner. J Cell Sci. 124:4332–4345. 2011. View Article : Google Scholar : PubMed/NCBI
45	Brito DA and Rieder CL: Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol. 16:1194–1200. 2006. View Article : Google Scholar : PubMed/NCBI
46	Galán-Malo P, Vela L, Gonzalo O, Calvo-Sanjuán R, Gracia-Fleta L, Naval J and Marzo I: Cell fate after mitotic arrest in different tumor cells is determined by the balance between slippage and apoptotic threshold. Toxicol Appl Pharmacol. 258:384–393. 2012. View Article : Google Scholar
47	Qi M, Yao G, Fan S, Cheng W, Tashiro S, Onodera S and Ikejima T: Pseudolaric acid B induces mitotic catastrophe followed by apoptotic cell death in murine fibrosarcoma L929 cells. Eur J Pharmacol. 683:16–26. 2012. View Article : Google Scholar : PubMed/NCBI
48	Liu WT, Chen C, Lu IC, Kuo SC, Lee KH, Chen TL, Song TS, Lu YL, Gean PW and Hour MJ: MJ-66 induces malignant glioma cells G2/M phase arrest and mitotic catastrophe through regulation of cyclin B1/Cdk1 complex. Neuropharmacology. 86:219–227. 2014. View Article : Google Scholar : PubMed/NCBI
49	Jin SQ and Zhan QM: Cell cycle checkpoint and tumour. Molecular Oncology. Liu S: People's Medical Publishing House; Beijing: pp. p3642005
50	Giovinazzi S, Bellapu D, Morozov VM and Ishov AM: Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy. Cell Cycle. 12:2598–2607. 2013. View Article : Google Scholar : PubMed/NCBI
51	Castedo M, Perfettini JL, Roumier T, Valent A, Raslova H, Yakushijin K, Horne D, Feunteun J, Lenoir G, Medema R, et al: Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene. 23:4362–4370. 2004. View Article : Google Scholar : PubMed/NCBI